Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does maximizing programmed cell death necessarily yield an optimum clinical advantage?

D Ou1, K M Anderson, W Leslie

  • 1Department of Pathology, University of Illinois Medical School at Chicago and the West Side V.A. Hospital, USA.

Medical Hypotheses
|June 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Modifiable factors related to life-space mobility in community-dwelling older adults: results from the Canadian Longitudinal Study on Aging.

BMC geriatrics·2020
Same author

Different radiation techniques to deliver therapeutic dose to the axilla in patients with sentinel lymph node-positive breast cancer: Doses, techniques challenges and clinical considerations.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2018
Same author

International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation.

The British journal of dermatology·2018
Same author

Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2018
Same author

Point mutation in p14<sup>ARF</sup> -specific exon 1β of CDKN2A causing familial melanoma and astrocytoma.

The British journal of dermatology·2017
Same journal

Calcitonin Gene-Related Peptide-Induced Central Sensitization: A Hypothesis for Long COVID Symptoms.

Medical hypotheses·2026
Same journal

Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?

Medical hypotheses·2025
Same journal

The Role of Hemispheric Sensory Shifts: Impacts on Stretch Reflex and Motor Plasticity Post-Stroke.

Medical hypotheses·2025
Same journal

Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition.

Medical hypotheses·2025
Same journal

How the Somatosensory System Adapts to the Motor Change in Stroke: A Hemispheric Shift?

Medical hypotheses·2024
Same journal

Unstable Plaque is a Treatable Cause of Cognitive Decline.

Medical hypotheses·2024
See all related articles

Inducing cancer cell death is not always beneficial, and the presence of Bcl-2, an anti-programmed cell death protein, may not be a negative prognostic indicator.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • The prevailing belief is that maximizing therapeutic induction of programmed cell death (apoptosis) in cancer cells is universally advantageous.
  • Bcl-2, a key anti-apoptotic protein, is consequently regarded as an unfavorable prognostic marker in cancer.

Purpose of the Study:

  • To challenge the universal applicability of inducing maximum cancer cell death as a therapeutic goal.
  • To re-evaluate the prognostic significance of Bcl-2 expression in cancer.

Main Methods:

  • This study critically examines existing literature and theoretical frameworks regarding apoptosis induction in cancer therapy.
  • Analysis focuses on the role of Bcl-2 and its implications in various cancer types and treatment responses.

Related Experiment Videos

Main Results:

  • The assumption that maximum induction of programmed cell death is always therapeutically desirable is questioned.
  • The prognostic value of Bcl-2, a major anti-programmed cell death protein, is not universally unfavorable as previously thought.

Conclusions:

  • The therapeutic strategy of universally inducing maximum cancer cell death requires nuanced consideration.
  • The prognostic significance of Bcl-2 expression warrants a more individualized assessment in cancer patients.